Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Calcibind

(cellulose)

PreclinicalSmall molecule

MMission Pharmacal

1

Indications

4

Total Trials

0

Active Trials

0

Competitors

1

FDA Application

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

CaffeineCompleted

CaffeinePreclinical

Completed

Clinical

Trials by Indication[1]

Pulmonary Sarcoidosis1 trial

Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis

Withdrawn·UUniversity of Maryland, Baltimore·Phase 2·NCT05910554

Osteoarthritis1 trial

Pharmacological Treatment In Osteoarthritis

Completed·MMaasstad Hospital·Phase 3·NCT01148043·200 enrolled

Caffeine1 trial

Effects of Caffeine Ingestion on the Biomechanics of Healthy Young Subjects

Completed·—·N/A·NCT06039358·15 enrolled

Bariatric Surgery1 trial

Treatment of Low Metabolic Rate Following Bariatric Surgery

Completed·OOregon Weight Loss Surgery, LLC·N/A·NCT01596907·218 enrolled

Regulatory

FDA Approval Timeline[4]

Dec 28, 1982

CALCIBIND

NDA NDA018757

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for cellulose. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — cellulose compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for cellulose. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA018757). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Mission Pharmacal company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMission Pharmacal

Related News